1) 平幸輝. 第6章 ERAS. In : 日本麻酔科学会・周術期管理チーム委員会, 編. 周術期管理チームテキスト. 第4版. 日本麻酔科学会 ; 2021. p.75-80.
2) Gan T, Belani K, Bergese S, et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2020 ; 131 : 411-48.
3) Twycross R, Wilcock A. Nausea and vomiting. In : Symptom management in advanced cancer. 3rd ed. Radcliffe Medical Press ; 2002. p.107.
4) Horn C, Wallisch W, Homanics G, et al. Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting. Eur J Pharmacol. 2014 ; 722 : 55-66.
5) Apfel C, Esa L, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting. Anesthesiology. 1999 ; 91 : 693-700.
6) Apfel C, Heidrich F, Jukar-Rao S, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth. 2012 ; 109 : 742-53.
7) Morino R, Ozaki M, Nagata O, et al. Incidence of and risk factors for postoperative nausea and vomiting at a Japanese Cancer Center : first large-scale study in Japan. J Anesth. 2013 ; 27 : 18-24.
8) 平幸輝, 堀田訓久, 竹内護. 術後悪心嘔吐への多面的アプローチ~乳癌手術後を例に~. 臨麻. 2019 ; 43 : 1091-7.
9) Apfel C, Kranke P, Katz M, et al. Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting : a randomized controlled trial of factorial design. Br J Anaesth. 2002 ; 88 : 659-68.
10) Wallenborn J, Gelbrich G, Bulst D, et al. Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone : randomised double blind multicentre trial. BMJ. 2006 ; 333 : 324-7.
11) Schaub I, Lysakowski C, Elia N, et al. Low-dose droperidol (< 1mg or < 15μg kg-1) for the prevention of postoperative nausea and vomiting in adults : quantitative systematic review of randomised controlled trials. Eur J Anaesthesiol. 2012 ; 29 : 286-94.
12) Jewer J, Wong M, Bird S, et al. Supplemental peri-operative intravenous crystalloids for postoperative nausea and vomiting : an abridged Cochrane systematic review. Anaesthesia. 2020 ; 75 : 254-65.